Nov 14, 2022 6:26pm EST Todos Medical to Host Third Quarter 2022 Earnings and Business Update Conference Call on November 15, 2022
Nov 10, 2022 10:33am EST Todos Medical Terminates Tollovid™ Products License & Distribution Agreement with T-Cell Protect Hellas S.A.
Oct 14, 2022 9:09am EDT Todos Medical CLIA/CAP Lab Provista Submits Emergency Use Authorization Application for MonkeyPox PCR Test to US FDA
Oct 06, 2022 8:00am EDT Todos Medical Announces Successful Pilot Launch of Suite of PCR Testing Services by CLIA/CAP Lab Provista Diagnostics
Sep 30, 2022 9:59am EDT Todos Medical Receives Two Notices of Allowance from USPTO for AI-Based TBIA Pan-Cancer Blood Diagnostics Platform
Sep 27, 2022 12:02pm EDT Todos Medical Announces USPTO Trademark Notice of Allowance for 3CL Protease Biomarker Diagnostics TolloTest™
Sep 22, 2022 4:02pm EDT Todos Medical Enters Into $50M Contract to Supply Tollovid™ and CBD Products to Retail Distributor Company Nerd Hemp
